Liangliang Xu

9PUBLICATIONS
9CO-AUTHORS
Dental therapeutics, pharmacology and toxicologyNatural products and bioactive compoundsMolecular targetsCancer cell biologyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 13, 2025
Atractylenolide I Attenuates Glucocorticoid-Induced Osteoporosis via Inhibiting NF-κB Signaling Pathway.

Yamei Liu, Xiaoqi Deng, Chen Chen

|Dec 21, 2023
Syringic acid promotes cartilage extracellular matrix generation and attenuates osteoarthritic cartilage degradation by activating TGF-β/Smad and inhibiting NF-κB signaling pathway.

Min Wang, Zhao Gao, Yage Zhang

|Nov 08, 2023
Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress.

Lingli Ding, Zhao Gao, Siluo Wu

|Nov 17, 2022
A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-<i>κ</i>B Signal Pathway and Reducing Reactive Oxygen Species.

Puiian Wong, Zheng Lv, Jinglan Li

|Jan 11, 2022
Nonwoven-based gelatin/polycaprolactone membrane loaded with ERK inhibitor U0126 for treatment of tendon defects.

Yonghui Hou, Bingyu Zhou, Ming Ni

|Mar 19, 2020
lncRNA-TINCR Functions as a Competitive Endogenous RNA to Regulate the Migration of Mesenchymal Stem Cells by Sponging miR-761.

Jiaqian Zheng, Yanni Huang, Ying Li

Pageof 2

Frequent Collaborators

1 joint publications

Bin Wang

1 joint publications

Wei He

1 joint publications

Gang Li

1 joint publications

Leilei Chen